To include your compound in the COVID-19 Resource Center, submit it here.

LX1033: Phase II data

Top-line data from the Phase Ib portion of a double-blind, dose-escalation, U.S. Phase I trial in 32

Read the full 172 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE